Stock Markets
Earnings call: SNDL reports growth in cannabis, challenges in liquor
SNDL Inc. (ticker: SNDL) announced its financial results for the third quarter of 2024 on November 10, 2024, highlighting sustained growth in its Cannabis operations and a record gross margin despite challenges in the Liquor segment. The company reported a slight decline in overall net revenue to $236.9 million year-over-year, primarily due to the Liquor segment’s performance. However, the Cannabis segment continued its upward trajectory with an 8% increase in revenue and a gross margin peak of 26.6%. SNDL also reported a positive free cash flow of $9.2 million and an improved cash balance, with no outstanding debt.
Key Takeaways
- SNDL’s Cannabis segment achieved an 11th consecutive quarter of revenue gains, with a 19% year-over-year growth reaching $25 million.
- The gross margin for Cannabis improved to a record 21.2%, contributing to a 30% increase in gross profit at $63 million.
- Net revenue slightly declined due to the Liquor segment, but overall operating income and cash balance improved.
- SNDL completed acquisitions of Indiva and Nova, aiming to strengthen its market position in Canadian edibles and retail.
- The company is on track for positive free cash flow for the full year 2024, supported by restructuring savings and operational efficiencies.
Company Outlook
- SNDL plans further growth and profitability, with a focus on the Canadian retail market and potential U.S. investments.
- The company is also considering ongoing share repurchases as part of its capital allocation strategy.
- Strategic initiatives, including a restructuring program, aim to achieve annual savings of over $20 million.
- SNDL is committed to enhancing employee engagement and operational improvements.
Bearish Highlights
- The Liquor segment experienced a decline, contributing to a slight decrease in overall net revenue year-over-year.
- The company faces challenges in the liquor retail market, although its private label offerings are gaining traction.
Bullish Highlights
- The Cannabis segment’s robust revenue growth and record gross margin indicate strong performance and market share gains.
- Recent acquisitions are expected to bolster SNDL’s position in the edibles market and Canadian retail growth.
- Productivity improvements and overhead savings are contributing to the company’s financial health.
Misses
- Despite overall revenue growth, the Liquor segment’s decline marks a setback for the company’s diversified portfolio.
Q&A highlights
- The acquisition of Indiva is expected to positively impact Q4 results, with nearly two months of performance contributing to the edibles category margins.
- SNDL is exploring facility consolidation to monetize noncore real estate, which could enhance cash balances for future investments.
- The company addressed the challenges of the illicit cannabis market in Canada, emphasizing the need for broader regulatory changes to support the legal market.
SNDL’s third-quarter earnings call demonstrated the company’s resilience and adaptability in the face of market fluctuations. With a strategic focus on growth, profitability, and employee engagement, SNDL is positioning itself for continued success in the evolving cannabis industry. The company’s proactive measures, including acquisitions and operational restructuring, are expected to drive future performance despite the current challenges in the liquor segment. Investors and stakeholders are encouraged to look forward to future updates on the company’s progress and developments.
InvestingPro Insights
SNDL Inc.’s recent financial results align with several key insights from InvestingPro. The company’s strong performance in the Cannabis segment, which achieved an 11th consecutive quarter of revenue gains, is reflected in InvestingPro’s data showing a 1.14% revenue growth over the last twelve months. This growth, coupled with the company’s strategic acquisitions and focus on operational efficiencies, supports the InvestingPro Tip that “net income is expected to grow this year.”
The company’s improved cash balance and absence of outstanding debt are consistent with an InvestingPro Tip indicating that SNDL “holds more cash than debt on its balance sheet.” This financial stability is further underscored by another tip stating that “liquid assets exceed short term obligations,” which bodes well for the company’s ability to fund future growth initiatives and potential U.S. investments.
Despite the challenges in the Liquor segment, SNDL’s overall financial health appears robust. The company’s market capitalization stands at $539.63 million, and it’s trading at a Price to Book ratio of 0.73, suggesting it may be undervalued relative to its assets. This aligns with the InvestingPro Tip that SNDL is “trading at a low revenue valuation multiple.”
Investors should note that while SNDL is not currently profitable over the last twelve months, analysts predict the company will be profitable this year, as indicated by another InvestingPro Tip. This projection aligns with SNDL’s outlook for positive free cash flow and the expected benefits from recent acquisitions and cost-saving measures.
For those seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for SNDL, providing a deeper understanding of the company’s financial position and market performance.
Full transcript – SNDL Inc (SNDL) Q3 2024:
Operator: Good morning, and welcome to SNDL’s Third Quarter 2024 Financial Results Conference Call. This morning, SNDL issued a press release announcing their financial results for the 2024 third quarter ended on September 30, 2024. This press release is available on the company’s website at sndl.com and filed on EDGAR and SEDAR as well. The webcast replay of the conference call will also be available on the sndl.com website. SNDL has also posted a supplemental investor presentation. In addition to the conference call presentation, we will be reviewing today on its sndl.com website. Presenting on this morning’s call, we have Zach George, Chief Executive Officer; and Alberto Paredero, Chief Financial Officer. Before we start, I would like to remind investors that certain matters discussed in today’s conference call or answers that may be given to questions could constitute forward-looking statements. Actual results could differ materially from those anticipated. Risk factors that could affect results are detailed in the company’s financial reports and other public filings that are made available on SEDAR and EDGAR. Additionally, all financial figures mentioned are in Canadian dollars, unless otherwise indicated. We will now make prepared remarks, then we’ll move on to analyst questions. I would now like to turn the call over to Zach George. Please go ahead.
Zachary George: Welcome to SNDL’s Q3 2024 Financial and Operational Results Conference Call. We are pleased to report robust revenue growth in our Cannabis segments, a record-breaking gross margins and positive free cash flow for the third quarter of 2024. Our Cannabis segments continued to show strong momentum, achieving steady revenue gains for the 11th consecutive quarter. Despite weaker demand in our Liquor segment, we delivered higher year-over-year margins and substantial growth in operating income for the segment. We achieved an all-time high gross margin of 26.6%, propelled by further margin expansion in Liquor retail and significant improvement within our Cannabis operations. Free cash flow was positive this quarter, supported by ongoing operational gains in gross margin and efficient working capital management. We remain on track to deliver positive free cash flow for the 2024 calendar year, meeting or even exceeding our guidance. This quarter and in recent days, we launched several strategic initiatives that we expect to drive SNDL towards long-term sustainable profitability. These include a restructuring program aimed at reducing corporate overheads, enhancing organizational efficiency and realizing annualized savings of more than $20 million. Additionally, we moved to privatize Nova through the acquisition of the remaining outstanding minority equity interest and just yesterday closed the acquisition of Indiva, enabling us to emerge as the leader in the Canadian infused edibles category. Together, these actions are strengthening our foundation and expanding our potential for future growth. Our leadership team is working on a number of additional initiatives and investment opportunities that we are excited to share as they come to fruition in future periods. Our solid balance sheet serves as a beacon for future opportunities, enabling us to allocate capital thoughtfully across both organic and inorganic investments. In the third quarter, we increased our cash balances from $183 million on June 30 to $263 million on September 30, 2024, and continue to have 0 outstanding debt. We have not raised cash through the issuance of shares since 2021, and our share repurchase program became active subsequent to the end of the quarter. I will now turn the call over to Alberto.
Alberto Paredero: Thank you, Zach. I want to remind you all that amounts discussed today are denominated in Canadian dollars, unless otherwise stated. Certain amounts referred to on this call are non-GAAP and non-IFRS measures. For definitions of these measures, please refer to SNDL’s management discussion and analysis document. Looking at our Q3 2024 financial highlights, we continue to see significant improvements in gross profit, gross margin and free cash flow. Net revenue in the third quarter of 2024 reached $236.9 million, a marginal decline compared to the prior year. This decline was driven by our Liquor retail segment, while our combined Cannabis segment posted a healthy 8% growth. Gross profit of $63 million represents a $14.4 million increase or 30% growth year-over-year with a substantial 610 basis points improvement in gross margin. This translates into another quarter of record gross margin, reaching 26.6%. Despite the significant improvements in margin and continued optimization of operating expenses, adjusted operating income was negative $16.6 million, a slight decrease compared to the prior year. This was mainly driven by an unfavorable $13.4 million fair value adjustment from our equity accounted investees in the quarter compared to a $6.6 million revaluation in the same quarter of the prior year. It is important to note that we only adjust operating income for restructuring charges and intangible impairments, which in the third quarter were limited to a $1.9 million restructuring charge. If we were to exclude the volatility created by quarterly fair value adjustment to our equity accounted investees, the improvement in adjusted operating income compared to the same third quarter of the prior year would have been $19 million. Free cash flow was positive in the quarter at $9.2 million, bringing the year-to-date free cash flow to a negative $2.8 million. We’re on pace to deliver positive free cash flow for the 2024 calendar year, in line with or ahead of guidance. Free cash flow in the quarter was lower than in the same period of prior year, driven by different management of phasing of retail inventory buildup throughout the year, as we will discuss in a few minutes. When examining the historical quarterly financial performance evolution, we clearly observe a few patterns. Net revenue in 2024 is relatively flat compared to 2023 as the strong growth in our Cannabis segment is being offset by market softness in the larger Liquor segment. We also see a clear trend of profitability improvement, both in gross profit and adjusted operating income. The same applies to free cash flow, where there is a noticeable upward trend compared to previous years. Additionally, we observed a more muted seasonality effect, thanks to our disciplined approach to working capital management. As we look at the contributions from each segment, we can see how the net revenue decline in Liquor is impacting the overall consolidated results despite the strong performance from Cannabis. When we add the $5.6 million net revenue growth from Cannabis retail, the $4.1 million from Cannabis operations and the negative $3.1 million in the Corporate segment related to the revenue elimination from Cannabis operations sales into our own retail, we arrived at a total of $6.5 million or 8% growth in Cannabis. In terms of gross profit, Liquor Retail shows a small decline of $0.3 million despite the larger revenue shortfall. Cannabis Retail contributes to an improvement of $0.7 million, while Cannabis operations is driving most of the growth with an impressive $14 million improvement. The aggregate of all the segment adds up to $14.4 million or 30% growth in gross profit. When looking at adjusted operating income, we can clearly see the significant step-up in profitability driven by our operating segments, offset by the volatility of the fair value adjustment in our Investment segment. Our Corporate segment shows a small unfavorable variance of $1.4 million, driven by inflation and the different phasing of onetime expenses, partly offset by restructuring productivity savings. Free cash flow is positive at $9.2 million in the third quarter of 2024, although it is a reduction compared to the same quarter in the previous year, this reduction is driven by a different phasing of inventory buildup between the quarters. We can see this more clearly on the next page. As we examine the drivers of free cash flow in the third quarter of 2024, we first noticed the negative $19.3 million in net income, primarily driven by the fair value adjustment in our Investment segment. Since this is a noncash item in our P&L, it is offset by noncash add-backs, which are higher in the third quarter compared to the previous 2 quarters for this reason. A benefit we saw in the third quarter was a collection of $10.7 million of accrued interest related to the repayment of the majority of Ascend and Jushi loans from SunStream. This interest was previously recorded in our P&L as part of the net asset value of the Investment segment. As the interest was collected, we see a positive impact on free cash flow. The repayment of the principal balance was associated with these 2 loans, while reported as an increase in cash is excluded from free cash flow calculation. The net change in inventory and other working capital is slightly positive at $0.9 million in the third quarter of 2024, with relatively small fluctuations between quarters. As we can see in the bar chart on the right of Page 7, in 2024, we have significantly less volatility in terms of inventory seasonality buildup. In previous years, we had a large increase in the first quarter, a moderate increase in the second and reductions in the second half of the year. In 2024, the buildup in the first half was much smaller. And as a result, the reduction in the second half will also be smaller. Let’s now look at each of the 3 operating segments, starting with Liquor Retail. Net revenue in the third quarter of 2024 for this segment was $144.6 million, a decline of $7.2 million or 4.8% compared to the prior year. While the decline is smaller than what we saw in the second quarter and revenue is growing quarter-over-quarter by $4 million, what is still impacted by the softness seen across North America. We continue to believe this is not a concern in terms of long-term growth potential for this segment. Despite these macro headwinds, we continue to expand gross margin, reaching 25.6% in the third quarter, an improvement of 100 basis points compared to last year. As a result of this margin expansion and efficiencies in the management of operating expenses, this segment’s operating income delivered significant growth of $3.5 million or 42.5% compared to the same quarter of 2023. Moving into Cannabis Retail. We saw net revenue in Q3 2024 of $81.1 million, a 7.4% increase compared to Q3 of 2023. This growth was mainly driven by same-store sales growth of 2.3%, new store openings and incremental revenue from our Dutch Love stores acquired earlier in the year. The gross margin of 25.5% represented a reduction of 100 basis points compared to the same period of last year due to several strategic pricing decisions aimed at increasing the store traffic. Adjusted operating income increased by $1 million or 28.1% compared to the prior year, driven by the gross profit improvement. Finally, our Cannabis Operations segment is once again showing the largest improvement, both in terms of growth and profitability. In the third quarter of 2024, this segment delivered net revenue growth of 19% year-over-year, reaching $25 million. All of this growth is organic and driven by increased provincial board and B2B distribution. By accelerating gross margin improvements through several productivity initiatives, the segment reached a new record of 21.2%, translated to $5.3 million in gross profit. This is a significant step-up compared to last year and previous quarters. Adjusted operating income was negative $0.6 million, marking an improvement of close to $14 million compared to the same period last year. In summary, our Cannabis business is experiencing strong growth, and we’re driving significant improvements in profitability and cash flow generation. We’re on pace to deliver our guidance of positive free cash flow for the full year, marking an important step in contributing to raise the bar and realize our full potential. I would now like to pass the call back to Zach to share a few more operational highlights for the quarter.
Zachary George: Thank you, Alberto. Beyond our financial performance, I would also like to highlight our core priorities: growth, profitability and people as each are fundamental to our long-term success. Starting with growth, our Cannabis segments have led with a combined net revenue increase of 7.4% year-over-year in Q3 and an impressive 90 basis point share gain in Canadian retail. Key drivers include quality execution, stabilization from 2023 store openings and the recent expansion into British Columbia. Our Cannabis Operations segment showed dynamic growth of 19%, driven by quality and innovation with 71 distribution points added this quarter and 491 year-to-date. Through M&A, we strengthened our portfolio with 2 very recent acquisitions, Indiva, making us a leader in Canadian edibles and the privatization of Nova, allowing SNDL shareholders to fully benefit from retail segment growth. In Liquor retail, despite this year’s market contraction, our private label offerings are growing to meet consumer demand for quality and affordability while driving margin accretion. Shifting to profitability. We are pleased to see continued strong momentum, leading to the record gross margin and $9 million of positive free cash flow in the quarter. Our positive free cash flow was enabled by efficiency improvements and interest income and not impacted by the noncash fair value adjustment of our investment portfolio. Productivity improvements totaled $15 million in Q3, largely from our Cannabis Operations segment through procurement, manufacturing and cultivation efficiencies. Data licensing in our Cannabis and Liquor Retail segments reached $4 million this quarter, a 6% increase from the second quarter. We also achieved $5 million in overhead savings, more than offsetting inflation and growth investments driven by efficiency gains across all segments as well as restructuring actions initiated in July. As you can see on the following page, summarizing the restructuring program progress, this program delivered more than $2 million in savings in the quarter, equivalent to an annualized run rate of $10 million or about 50% of our planned target. Finally, we remain committed to our people as a top strategic priority. In the second quarter, we launched a strategic talent review to identify key roles as well as development and succession plans. We continued deploying several community engagement initiatives, offering all of our team members the possibility to participate in sessions around mental and physical well-being and also rolled out an employee recognition program with over 40 awards being presented across our organization, celebrating the amazing contributions from our team members. Last but not least, we continue the development of a total reward structure that aligns our compensation philosophy with both individual and company performance. My conviction and confidence in our team that is setting new records with each quarter are at all-time highs. Our dedicated leaders have the expertise and drive to unlock SNDL’s significant potential. I’d like to thank our entire team for their contributions and our shareholders for their continued trust. I will now pass the call back to the operator for analyst Q&A. Thank you.
Operator: [Operator Instructions] The first question comes from the line of Frederico Gomes from ATB Capital Markets.
Frederico Gomes: First question on the Nova acquisition. Could you talk about, I mean, why you decided to acquire that remaining stake? And strategically, I guess, just what sort of advantages do you see in owning — fully owning Nova as opposed to a majority stake?
Zachary George: Frederico, thank you very much for the question. So as you know, this is a very competitive space with excess taxation and reasonably low margins. So the acquisition of that minority stake in Nova is going to ensure that SNDL shareholders can get the full benefit of the cash flow and earnings potential of that retail business.
Frederico Gomes: On your Cannabis operations, quite a significant improvement in margins there. Can you talk a little bit about the key drivers behind that margin improvement? And in terms of your expectations going forward, do you expect to continue to see margin expanding? And if so, where is that going to come from?
Alberto Paredero: Yes. Fred, this is Alberto. So yes, actually, most of the — or all of the improvements are driven by an end-to-end holistic productivity program that the management team of the segment has put in place already since the end of last year. As you remember, in the fourth quarter of 2023, we decided to exit or close the Olds facilities that created already a bump in the gross margin and the profitability of the segment in the first couple of quarters. Since then, we have been driving efficiencies in labor and automation in our manufacturing facilities. We’re seeing a ramp-up in our cultivation assets as well. So as we were already anticipating in the previous quarters, we were expecting to be over 20% by the end of this year. So we’re happy to see that already happening in the second — in the third quarter. And we have a long list of additional initiatives, including the additional capacity utilization from the growth that the business has seen and more automation and efficiency improvements that will continue to push that gross margin further up.
Zachary George: Yes. Frederico, you’ve been following our story for quite some time, and you’re well aware that in the earlier days several years ago, Olds was sitting with exposure to a power jurisdiction that really challenged its competitiveness. And so as we’ve built the business, leaned more into procurement and broadened out our manufacturing capabilities, we have been able to eliminate exposure to high-cost biomass, which would really impair COGS. And so that was a meaningful first step that’s been showing up through the numbers in the last year. And our President of Cannabis, Tyler Robson, has been leading for a number of initiatives that are being very impactful in today’s environment, including managing mix, SKU creep, automation. And so there’s a number of efficiencies that are still in play. And we’re very confident in the team being in a position where they actually understand the drivers here and can action against the economic outcomes that we’re seeking. So when we think about room for expansion, do we think that we can take gross margins to a zone where they have a 3 handle, the answer is absolutely. So a lot more to come here.
Frederico Gomes: Perfect. And then just one more for me. In regards to capital allocation, I know that you mentioned a bit of this, but how are you looking at, I guess, different growth options and investments in Canada, the U.S. or other geographies internationally? And the second part of the question also in regards to your buyback, you obviously repurchased some shares recently. So can you comment on those repurchases? Is it something that you intend to continue to do tap that buyback? And in terms of the valuation here, you bought it at $1.90. So how do you view your valuation right now at over $2.20?
Zachary George: So there’s a few questions in there. Just starting with capital allocation. It’s going to be a very similar answer consistent with what we spoke about last quarter, Frederico. So two real key priorities in terms of capital allocation are going to be continued growth in Canadian retail and also investment in – potential investment in assets in the U.S. Both of those pillars are part of our core multiyear strategic plan. And when you think about the repurchase of shares, we absolutely want to take advantage of repurchasing shares at levels that we think reflect a discounted valuation. The transactions that you referenced were part of a nondiscretionary trading plan, which we were able to execute through a blackout period. And this is something that will be regularly reviewed by our Board in terms of scale and levels at which to purchase. So we expect to be in a position to acquire shares on an ongoing basis. I think there’s a misconception out there that somehow a share repurchase plan is best used to prop up a security. And that’s just something we will never do. It’s really for the benefit of long-term holders as we’re reflecting really strongly into positive free cash flow and ultimately net income.
Operator: Our next question comes from the line of Yewon Kang from Canaccord Genuity.
Yewon Kang: So my first question is regarding the recently completed Indiva acquisition. Through that transaction, SNDL obtained a facility in London. And my understanding is now that the company has 2 edibles-focused facility, including the LYF facility in Kelowna. Just wanted to ask about if you guys have any plans to consolidate these facilities in the future. And I know it’s only been a few weeks since the acquisition closed, but could you guys give us a color on the upside you’re seeing from integrating Indiva brands onto your distribution channel?
Zachary George: It’s a great question. And I’ll let Alberto talk a little bit about our broader planning. The acquisition actually closed yesterday, so well inside of a few weeks. And we’re very excited about the addition of the Indiva team and product mix to our broader business. You will see an impact in Q4 from almost 2 months’ worth of performance there. And given the margin profile that’s available in the edibles category, we see that this acquisition being margin accretive to our upstream manufacturing portfolio. So it’s something we’re very excited about. I would answer the question on real estate more broadly. There are a number of opportunities we have for facility consolidation that will result in noncore real estate being available for monetization, which should further bolster cash balances and enable us to recycle capital into accretive opportunities. We’re going to be working on a longer-term prudent and thoughtful integration plan with Indiva, and we’ll be able to provide more details on that in the coming months.
Alberto Paredero: Yes. Just to add the — both our teams, the existing of SNDL and the team from Indiva now joining our family, they are already collaborating and exploring the different synergy opportunities that we have across revenue, supply chain and operating expenses. We do have a long list of ideas that are being analyzed to make sure we make the right choices and the right decisions. But certainly, we do see a lot of synergies. We’ll be able to share where those opportunities are as we complete the analysis in the next several weeks.
Yewon Kang: And just a second question on the retail environment for Cannabis dispensaries. So a couple of your peers have called out some of the pressures that they’re seeing in Ontario, specifically in relation to the illicit stores popping up all around the province. Just wanted to ask if you have been seeing similar pressures on your retail stores as a result of this illicit market that’s popping up again and what your thoughts are going forward in terms of the provincial regulators coming in to regulate these illegal stores?
Zachary George: It’s a great question. It’s also a very difficult question. The impact of the illicit market in the Canadian – within the Canadian landscape has been constant. I wouldn’t say that there’s some new emergence of headwinds. They’ve been there in different forms in most provinces. What we do know is that there is some degree of enforcement happening, and we’ve seen pockets and incidents that are encouraging in terms of our provincial government’s willingness to stamp out the illicit market. We still need broader regulatory change to help support that. And we believe that you’re going to see additional rational reform come through in 2025. Even something as small as changing the limits on edibles from 10 milligrams to 100 would have a material impact on illicit market trade. Again, no one’s coming to save us here. So what we do know is that convenience and value are winning with the consumer at the end of the day, and we’re able to offer a very competitive selection that is delighting consumers. And so we’re going to continue to focus on being strong competitors in the legal market.
Operator: [Operator Instructions] This concludes the question-and-answer session. I would like to turn the conference back over to Zach George for any closing remarks.
Zachary George: Thank you, operator, and thank you to everyone for joining us for the call. We look forward to updating you in the coming months. Have a great day.
Operator: This concludes today’s conference call. You may disconnect your lines. Thank you for participating, and have a pleasant day.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Stock Markets
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman
San Francisco, California–(Newsfile Corp. – December 25, 2024) – On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling announcement that it was discontinuing a Phase 2 study for its lead product, azelaprag, intended to treat metabolic diseases such as obesity.
Hagens Berman has opened an investigation and urges investors in BioAge who purchased shares in the company’s IPO or on the open market and suffered substantial losses to submit your losses now.
Visit: www.hbsslaw.com/investor-fraud/bioa
Contact the Firm Now: BIOA@hbsslaw.com
844-916-0895
BioAge Labs, Inc. (BIOA) Investigation:
The investigation is focused on the propriety of BioAge’s disclosures about the safety data and other matters related to azelaprag, which the company said in its IPO documents has been “well-tolerated in 265 individuals across eight Phase 1 clinical trials.”
BioAge’s disclosures came into question after the market closed on December 6, 2024, when the company announced the discontinuation of the STRIDES Phase 2 clinical trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity. BioAge said that liver transaminitis was observed in patients receiving azelaprag.
This news drove the price of BioAge shares down almost 80% on December 9, 2024.
“We’re focused on whether BioAge was transparent to investors about the azelaprag safety profile before the December 6 announcement,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in BioAge and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »
If you’d like more information and answers to frequently asked questions about the BioAge investigation, read more »
Whistleblowers: Persons with non-public information regarding BioAge should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email BIOA@hbsslaw.com.
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235182
Stock Markets
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
CELH Investors with Losses Encouraged to Contact the Firm
San Francisco, California–(Newsfile Corp. – December 25, 2024) – Celsius Holdings (NASDAQ:), Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company’s financial performance, especially concerning its key customer, PepsiCo (NASDAQ:).
Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your losses now.
Class Period: Feb. 29, 2024 – Sept. 4, 2024
Lead Plaintiff Deadline: Jan. 21, 2025
Visit: www.hbsslaw.com/investor-fraud/celh
Contact the Firm Now: CELH@hbsslaw.com
844-916-0895
Celsius Holdings, Inc. (CELH) Securities Class Action (WA:):
The lawsuit alleges that during the Class Period, Celsius failed to disclose to investors several critical points:
- Oversold Inventory: Celsius significantly oversold inventory to Pepsi beyond demand, leading to a potential drastic reduction in future purchases.
- Declining Sales: As Pepsi depleted its overstock, Celsius’ sales were projected to decline, impacting its financial health and outlook.
- Unsustainable Sales Rates: The sales rates to Pepsi were unsustainable and created a misleading impression of the company’s performance.
- Misleading Metrics: Consequently, Celsius’ business metrics and financial prospects were overstated
The situation came to light on May 28, 2024, when Celsius’ stock price plummeted nearly 13% following reports from Nielsen indicating slowed sales growth. Analysts highlighted the possibility of significantly reduced sales as Pepsi cut back its inventory.
The stock took another hit on September 4, 2024, dropping over 11% after a company presentation revealed a shortfall of $100 million to $120 million in Pepsi orders compared to the previous year. It was also disclosed that Pepsi had held several million excess cases over the last 18 months.
These revelations have led shareholder rights firm Hagens Berman to investigate the allegations.
“We’re investigating whether Celsius deliberately painted an overly optimistic picture of its relationship with Pepsi, misleading investors about the true state of its financial health and sales sustainability,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Celsius and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »
If you’d like more information and answers to frequently asked questions about the Celsius case and our investigation, read more »
Whistleblowers: Persons with non-public information regarding Celsius Holdings should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CELH@hbsslaw.com.
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235180
Stock Markets
Suriname fugitive ex-President Desi Bouterse dead at 79
By Ank Kuipers
PARAMARIBO (Reuters) -Suriname’s fugitive former President Desi Bouterse has died aged 79, the country’s government said on Wednesday, almost a year after he fled authorities to avoid jail following his conviction over the murder of 15 political activists in 1982.
“The government has been informed through the family and its own investigations of the passing of Mr. D. Bouterse, ex-President of the Republic of Suriname,” Foreign Minister Albert Ramdin told Reuters.
The former leader died on Tuesday, the government said, without confirming where, or even in which country. Last week Surinamese authorities raided his home – where supporters gathered to pay their respects on Wednesday morning – but did not find him.
Surinamese President Chan Santokhi, who investigated the case as a police commissioner and later as justice minister, expressed condolences to Bouterse’s family and urged calm in a statement.
“In the spirit of the holiday season and year-end, the president calls on all to remain dignified and calm, maintain peace and order and engage in prayer in the spirit of these special days,” the statement said.
Bouterse dominated politics in the tiny South American country for decades, leading a coup in 1980 and finally leaving office in 2020.
In 2019 he and six others were convicted for their role in the 1982 murders of 15 leading government critics – including lawyers, journalists, union leaders, soldiers and university professors – for which Bouterse received a 20-year prison sentence.
Bouterse had claimed the murdered men were connected to a planned invasion of the former Dutch colony.
Following years of legal back and forth, Bouterse was ordered to report to prison in January but he did not show up on the appointed date.
Though Bouterse avoided prison by going on the run, Reed Brody, a U.S. war crimes prosecutor who monitored the case for the International Commission of Jurists, said justice had caught up with the convicted former president before he died.
“Thanks to the victims’ relatives and their supporters who never gave up, Bouterse will go down in history as a convicted murderer,” Brody said.
The former president’s family will make a statement later on Wednesday, members of his political party told journalists.
- Forex2 years ago
Forex Today: the dollar is gaining strength amid gloomy sentiment at the start of the Fed’s week
- Forex2 years ago
How is the Australian dollar doing today?
- Forex2 years ago
Unbiased review of Pocket Option broker
- Forex2 years ago
Dollar to pound sterling exchange rate today: Pound plummeted to its lowest since 1985
- Cryptocurrency2 years ago
What happened in the crypto market – current events today
- World2 years ago
Why are modern video games an art form?
- Commodities2 years ago
Copper continues to fall in price on expectations of lower demand in China
- Forex2 years ago
The dollar is down again against major world currencies